Application of endoscopic ultrasound-guided-fine needle aspiration combined with cyst fluid analysis for the diagnosis of mediastinal cystic lesions.
Cystic lesion
EUS-FNA
diagnosis
mediastinum
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
18
09
2018
revised:
01
11
2018
accepted:
03
11
2018
pubmed:
28
11
2018
medline:
8
2
2020
entrez:
28
11
2018
Statut:
ppublish
Résumé
Mediastinal cystic lesions account for approximately 15-20% of all mediastinal masses and are difficult to differentiate because of similar imaging manifestation. The aim of this study was to differentiate mediastinum cystic lesions through endoscopic ultrasound-guided-fine needle aspiration (EUS-FNA) and parameters from cyst-fluid analysis. Over a period of eight years, 37 patients suspected with mediastinal cystic lesions were assessed. Cyst fluid was collected via EUS-FNA and further examined using cytological and biochemical techniques. Definitive diagnosis was established based on cytology, surgical pathology, and/or clinical follow-up. Based on the final pathological reports or long-term follow-up, 19 patients were diagnosed with benign cysts, 14 with benign or malignant tumors, 2 with tuberculosis, 1 with an abscess, and 1 with a pancreatic pseudocyst. Computed tomography or magnetic resonance imaging mistakenly distinguished eight cases as solid masses (27.03%), but EUS revealed cystic characteristics. Carcinoembryonic antigen and lactate dehydrogenase (LDH) were evaluated from the cyst fluid obtained by EUS-FNA. There was no statistically significant difference in carcinoembryonic antigen values between benign and malignant cysts; however the average LDH value in the malignancy group was significantly higher than in the benign group. EUS-FNA showed great potential for differentiating mediastinal lesions by combining imaging manifestation and cytological examination. The elevated LDH value from cyst fluid chemical analysis could be used as an auxiliary indicator for diagnosing malignancy.
Sections du résumé
BACKGROUND
Mediastinal cystic lesions account for approximately 15-20% of all mediastinal masses and are difficult to differentiate because of similar imaging manifestation. The aim of this study was to differentiate mediastinum cystic lesions through endoscopic ultrasound-guided-fine needle aspiration (EUS-FNA) and parameters from cyst-fluid analysis.
METHODS
Over a period of eight years, 37 patients suspected with mediastinal cystic lesions were assessed. Cyst fluid was collected via EUS-FNA and further examined using cytological and biochemical techniques. Definitive diagnosis was established based on cytology, surgical pathology, and/or clinical follow-up.
RESULTS
Based on the final pathological reports or long-term follow-up, 19 patients were diagnosed with benign cysts, 14 with benign or malignant tumors, 2 with tuberculosis, 1 with an abscess, and 1 with a pancreatic pseudocyst. Computed tomography or magnetic resonance imaging mistakenly distinguished eight cases as solid masses (27.03%), but EUS revealed cystic characteristics. Carcinoembryonic antigen and lactate dehydrogenase (LDH) were evaluated from the cyst fluid obtained by EUS-FNA. There was no statistically significant difference in carcinoembryonic antigen values between benign and malignant cysts; however the average LDH value in the malignancy group was significantly higher than in the benign group.
CONCLUSION
EUS-FNA showed great potential for differentiating mediastinal lesions by combining imaging manifestation and cytological examination. The elevated LDH value from cyst fluid chemical analysis could be used as an auxiliary indicator for diagnosing malignancy.
Identifiants
pubmed: 30480367
doi: 10.1111/1759-7714.12924
pmc: PMC6360264
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
156-162Informations de copyright
© 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Références
Chest. 2007 Feb;131(2):539-48
pubmed: 17296659
J Surg Oncol. 1989 Jun;41(2):103-8
pubmed: 2724976
Gastroenterology. 1997 Apr;112(4):1087-95
pubmed: 9097990
J Bronchology Interv Pulmonol. 2011 Jul;18(3):265-8
pubmed: 23208572
Gastrointest Endosc. 2003 Sep;58(3):362-8
pubmed: 14528209
Endoscopy. 2010 Jun;42(6):462-7
pubmed: 20432206
J Gastrointest Oncol. 2011 Dec;2(4):195-8
pubmed: 22811850
Clin Respir J. 2015 Apr;9(2):203-13
pubmed: 25849297
Eur J Cancer. 2009 May;45(8):1389-96
pubmed: 19124238
Cancer. 2004 Aug 25;102(4):253-8
pubmed: 15368318
Acta Cytol. 2003 Jul-Aug;47(4):571-4
pubmed: 12920748
Eur J Cardiothorac Surg. 2006 Apr;29(4):627-9; discussion 629
pubmed: 16476541
Lung. 2017 Oct;195(5):653-660
pubmed: 28656381
Diagn Cytopathol. 2007 Jan;35(1):43-6
pubmed: 17173292
J Comput Assist Tomogr. 1995 Mar-Apr;19(2):188-91
pubmed: 7890839
Kyobu Geka. 2001 Aug;54(9):805-8
pubmed: 11517557
Endoscopy. 2005 Sep;37(9):833-9
pubmed: 16116534
Endosc Ultrasound. 2014 Jul;3(3):152-60
pubmed: 25184121
Endoscopy. 2003 Sep;35(9):791-3
pubmed: 12929034
Int J Surg Pathol. 2007 Apr;15(2):187-91
pubmed: 17478780
Radiographics. 2002 Oct;22 Spec No:S79-93
pubmed: 12376602
Cancer Biomark. 2016;16(3):415-23
pubmed: 27062698
Eur J Cardiothorac Surg. 2014 May;45(5):787-98
pubmed: 24578407
Gastrointest Endosc. 2005 Oct;62(4):575-80
pubmed: 16185972
Respiration. 1981;42(2):135-7
pubmed: 7313333
Eur Respir J. 2006 Dec;28(6):1264-75
pubmed: 17138681
J Pediatr Surg. 1997 Oct;32(10):1408-13
pubmed: 9349757
JAMA. 2008 Feb 6;299(5):540-6
pubmed: 18252884
Radiology. 2000 Nov;217(2):441-6
pubmed: 11058643
J Clin Imaging Sci. 2012;2:33
pubmed: 22919547
Cytopathology. 2010 Feb;21(1):6-26
pubmed: 20015257